Literature DB >> 2398356

Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A.

D J Begley1, L K Squires, B V Zloković, D M Mitrović, C C Hughes, P A Revest, J Greenwood.   

Abstract

Uptake of the immunosuppressive lipophilic peptide cyclosporin A has been measured by a number of techniques. The brain uptake index (BUI) technique in the rat yields only a small BUI value that is not significantly different from that of sucrose and mannitol and is comparable to other published BUI values for this compound. Brain perfusion studies in the guinea pig produce a unidirectional cerebrovascular permeability constant (Kin) of 1.2 +/- 0.28 microliter g-1 min-1 for the hippocampus. Intravenous bolus injection techniques also in the guinea pig characteristically produce a larger Kin value of 2.53 +/- 0.38 microliter g-1 min-1 for the same brain region, even after a correction for the inulin space of the tissue has been made. Apparent penetration of cyclosporin A into the cerebrospinal fluid (CSF) determined with the intravenous bolus injection technique is small with a Kin of 0.79 +/- 0.07 microliter g-1 min-1. However it is suggested that the radioactivity present in CSF is largely tritiated water. Studies with cultured cerebral endothelial cells from the rat have also been carried out and show that the cultured cells take up and accumulate cyclosporin A in vitro, achieving a tissue-to-medium ratio of 20 after 25 min of incubation. It is suggested that cyclosporin A is primarily taken up from lipoprotein at the blood-brain interface but, because of tight junctions at the blood-brain and blood-CSF barriers, becomes effectively trapped in the cerebral endothelial cells and the choroid plexus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2398356     DOI: 10.1111/j.1471-4159.1990.tb03128.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  26 in total

1.  The effect of protein binding on ivermectin uptake by bovine brain microvessel endothelial cells.

Authors:  K L Audus; S R Knaub; F L Guillot; J M Schaeffer
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

2.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.

Authors:  Robert D Bell; Ethan A Winkler; Itender Singh; Abhay P Sagare; Rashid Deane; Zhenhua Wu; David M Holtzman; Christer Betsholtz; Annika Armulik; Jan Sallstrom; Bradford C Berk; Berislav V Zlokovic
Journal:  Nature       Date:  2012-05-16       Impact factor: 49.962

Review 3.  Mechanisms of blood-brain barrier breakdown.

Authors:  J Greenwood
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

4.  Genetic inactivation of the p66 isoform of ShcA is neuroprotective in a murine model of multiple sclerosis.

Authors:  Kimmy G Su; Costanza Savino; Gail Marracci; Priya Chaudhary; Xiaolin Yu; Brooke Morris; Danielle Galipeau; Marco Giorgio; Michael Forte; Dennis Bourdette
Journal:  Eur J Neurosci       Date:  2012-01-25       Impact factor: 3.386

5.  Combination of cyclosporin A and prednisolone for juvenile cellulitis concurrent with hindlimb paresis in 3 English cocker spaniel puppies.

Authors:  Chul Park; Jong-Hyun Yoo; Ha-Jung Kim; Byeong-Teck Kang; Hee-Myung Park
Journal:  Can Vet J       Date:  2010-11       Impact factor: 1.008

Review 6.  Delivering peptides to the central nervous system: dilemmas and strategies.

Authors:  W A Banks; A J Kastin; C M Barrera
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

7.  Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier.

Authors:  L Fenart; V Buée-Scherrer; L Descamps; C Duhem; M G Poullain; R Cecchelli; M P Dehouck
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

8.  Evaluation of the role of P-glycoprotein in ivermectin uptake by primary cultures of bovine brain microvessel endothelial cells.

Authors:  J M Rose; S L Peckham; J L Scism; K L Audus
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

9.  Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism.

Authors:  S P Butcher; D C Henshall; Y Teramura; K Iwasaki; J Sharkey
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 10.  Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

Authors:  Boris Decourt; Debomoy K Lahiri; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.